Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model
about
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for interventionNeuroendocrine differentiation in prostate cancerNeuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failureThe neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor.Use of nude mouse xenograft models in prostate cancer research.Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC-3 human prostate cancer cells.Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostate and in prostate carcinoma.Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells.The Siah2-HIF-FoxA2 axis in prostate cancer – new markers and therapeutic opportunities.Current mouse and cell models in prostate cancer research.Catalytically active peptidylglycine alpha-amidating monooxygenase in the media of androgen-independent prostate cancer cell lines.Neuroendocrine transdifferentiation induced by VPA is mediated by PPARgamma activation and confers resistance to antiblastic therapy in prostate carcinoma.Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer.Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines.Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer.Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft model.Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.
P2860
Q21129293-3A05A79E-C169-4A69-9E9B-4D18989C2707Q24657547-305E1A16-5DE4-4B90-A18C-2838009F2706Q26859201-DA2356AB-3E44-4EDF-888E-0871087C047FQ30434799-F7EE6686-3DEE-422F-92B8-42F99BE8F36EQ33947227-A634BED5-92A1-45CD-90F7-417DB60A5B3EQ34355852-B6F4F08C-BF10-4D82-88C5-8BC1B0C48ACAQ34580852-5BB3C729-A677-4AB6-A647-9466865372AFQ35141115-5961CDC5-2F4D-4A89-9F71-9C1D9A378AB5Q36143611-7C9EF47A-A258-4945-8A72-B5F84DE63F1AQ37564369-E0278BAC-950B-4B04-B59B-B46264D32DC4Q37805340-05F3F90A-F1AB-47A7-BB36-7F4B14CA5F41Q38098499-62B2DFCC-23C4-4EF6-84D2-9072EF4868B2Q39933093-F68AA3B1-9963-453B-B2FA-02FDBF898C1EQ40010738-6BD13BE6-153A-46EA-8822-A912C42ED6F2Q40526439-A1AA15C4-D6D5-402C-9E2E-F255A3C8E28AQ40915126-50CF8635-92AB-45E1-BF50-1D7EAD4FD9C0Q41764330-5AAA46EA-2656-4AD2-A328-F023A8E219B7Q42462214-2A4B693B-666E-4CC9-BCC7-9D3BE27C7583Q53958238-9591B75E-7F66-4CFA-B4E6-7D3D1CDD982E
P2860
Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Kinetics of neuroendocrine dif ...... human prostate xenograft model
@ast
Kinetics of neuroendocrine dif ...... human prostate xenograft model
@en
Kinetics of neuroendocrine dif ...... human prostate xenograft model
@nl
type
label
Kinetics of neuroendocrine dif ...... human prostate xenograft model
@ast
Kinetics of neuroendocrine dif ...... human prostate xenograft model
@en
Kinetics of neuroendocrine dif ...... human prostate xenograft model
@nl
prefLabel
Kinetics of neuroendocrine dif ...... human prostate xenograft model
@ast
Kinetics of neuroendocrine dif ...... human prostate xenograft model
@en
Kinetics of neuroendocrine dif ...... human prostate xenograft model
@nl
P2093
P2860
P3181
P1476
Kinetics of neuroendocrine dif ...... human prostate xenograft model
@en
P2093
F H Schröder
G J Martens
G J van Steenbrugge
T H van der Kwast
W M Van Weerden
P2860
P304
P3181
P356
10.1016/S0002-9440(10)65300-X
P407
P50
P577
1999-02-01T00:00:00Z